Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer

Clinical trial NCT01046461 · UNKNOWN

Trial details

NCT number: NCT01046461
Sponsor: Hallym University Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumour Postoperative Nausea and Vomiting

Start date: 2010-01-01
Primary completion: 2012-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.